Essential Reviews in Geriatric Psychiatry
Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial
Publication
, Chapter
Tuck, A; Riordan, PA
January 1, 2022
The investigators conducted a randomized, double-blind, placebo-controlled trial that compared cognitive behavioral therapy, zopiclone, and placebo for the treatment of insomnia in older adults.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Tuck, A., & Riordan, P. A. (2022). Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial. In Essential Reviews in Geriatric Psychiatry (pp. 381–386). https://doi.org/10.1007/978-3-030-94960-0_66
Tuck, A., and P. A. Riordan. “Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial.” In Essential Reviews in Geriatric Psychiatry, 381–86, 2022. https://doi.org/10.1007/978-3-030-94960-0_66.
Tuck A, Riordan PA. Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial. In: Essential Reviews in Geriatric Psychiatry. 2022. p. 381–6.
Tuck, A., and P. A. Riordan. “Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial.” Essential Reviews in Geriatric Psychiatry, 2022, pp. 381–86. Scopus, doi:10.1007/978-3-030-94960-0_66.
Tuck A, Riordan PA. Cognitive Behavioral Therapy Versus Zopiclone for the Treatment of Chronic Primary Insomnia in Older Adults: A Randomized Controlled Trial. Essential Reviews in Geriatric Psychiatry. 2022. p. 381–386.